Hold an Afternoon Tea This August, drink tea, eat cake, play games, and more to help fund our research and support.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 207 results We welcome NICE approval of pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) for routine use on the NHS 25 May 2022 2 min read We comment on new research which shows the drug trastuzumab deruxtecan may benefit even more breast cancer patients 05 Jun 2022 1 min read We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read We respond to MP Dawn Butler's mission to find the Million Missing Mammograms 02 Aug 2022 1 min read We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read Previous 1 ... 12 ... 18 Next
We welcome NICE approval of pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) for routine use on the NHS 25 May 2022 2 min read
We comment on new research which shows the drug trastuzumab deruxtecan may benefit even more breast cancer patients 05 Jun 2022 1 min read
We respond to new findings from the Lumina trial which suggest some patients could avoid radiotherapy 07 Jun 2022 1 min read
We respond to the Royal College of Radiologists’ clinical radiology and clinical oncology census reports for 2021 10 Jun 2022 1 min read
We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes 15 Jun 2022 1 min read
We respond to the approval of breast cancer drug abemaciclib for routine use on the NHS 17 Jun 2022 2 min read
Breast Cancer Now celebrates landmark victory as Trodelvy is recommended for use on the NHS in England 14 Jul 2022 2 min read
Breast Cancer Now welcomes NICE decision to recommend alpelisib with fulvestrant for routine use on the NHS 14 Jul 2022 2 min read
We respond to Macmillan Cancer Support's warning that "almost 50,000 people are still missing a cancer diagnosis in the UK" 26 Nov 2021 1 min read
We respond to a new report from The Institute of Cancer Research, London, into cancer clinical trials 09 Dec 2021 1 min read
We respond to recent announcements around the COVID-19 booster jabs roll-out and share our concerns around potential disruption to breast cancer services caused by Omicron 13 Dec 2021 2 min read
